Studies Find Biotechnology Anemia Drug Shows Promise in Treating Several Diseases
Article Abstract:
Amgen Inc., Johnson & Johnson, Warren Pharmaceuticals and a variety of independent researchers are looking at new ways to use erythropoietin. The anemia drug shows promise in the treatment of brain damage from stroke, schizophrenia, AIDS-related dementia and nerve diseases.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Patients in Test Won't Get Drug, Amgen Decides
Article Abstract:
A group of Amgen clinical trial participants who had benefited from an experimental Parkinson's drug are frustrated that the company has forbidden them to continue with the therapy.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
In Drug Research, Some Guinea Pigs Are Now Human
Article Abstract:
Pharmaceutical companies are increasingly using quick human trials to gauge a drug's efficacy before committing to long-term studies.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Sun Life Financial to review its sales commission practices. Royal group ousts top 3 executives
- Abstracts: Sex and love: The new world. The fine art of letting go. A writer who beat the odds: Hillenbrand battled chronic fatigue to pen a best seller
- Abstracts: The Oil Market Refuses to Heed Positive News. A Tanker Shortage Contributes to Rising Oil Costs
- Abstracts: Hybrid-Car Tinkerers Scoff at No-Plug-In Rule. Sure, It's Pragmatic. But Stylish? The Minivan Is Getting a Makeover
- Abstracts: U.S. Allows Continued Sale Of Abbott Weight-Loss Drug. New York's Pension Fund Files Own Suit Against Merck. $60 Million Deal In Pfizer Suit